Varian Medical Systems led the robotic-assisted ultrasound device developer's series C round, which also included Johnson & Johnson Innovation - JJDC.

HistoSonics, the US-headquartered developer of a soundwave-based medical treatment device, completed a $54m series C round yesterday that was led by cancer treatment technology provider Varian Medical Systems. Johnson & Johnson Innovation – JJDC, the corporate venturing arm of medical group Johnson & Johnson, also took part in the round, as did venture capital firm…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.